Figure 2.

Serum phosphate levels. (A) during the open-label, lanthanum carbonate dose-titration phase (safety set); (B) during the randomized, placebo-controlled, parallel-group phase (per protocol set). ^*p < 0.01 vs placebo. Data are presented as mean ± 95% confidence interval.